SCHEMBL6188945

SCHEMBL6188945

CCC(CC)C(=O)Nc1ccc2[nH]c(C)c(C(=O)c3c(Cl)cccc3Cl)c2c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
MEN1 O00255 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186843 0.91 ALDH1A1 (0.40) KMT2AGAAALDH1A1KDM4EHPGD
SCHEMBL6185825 0.88 TYK2 (0.45) KMT2AMEN1GAASMN1; SMN2ALDH1A1
SCHEMBL6185686 0.82 DAPK3 (0.48) KMT2AMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL6189327 0.81 HPGD (0.46) KMT2AMEN1GAASMN1; SMN2ALDH1A1
SCHEMBL6185706 0.80 MAOB (0.42) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL6186285 0.79 MAOA (0.49) GAASMN1; SMN2ALDH1A1KDM4ENPSR1
SCHEMBL6185134 0.78 MAOA (0.54) SMN1; SMN2ALDH1A1KDM4ENPSR1HPGD
SCHEMBL6188852 0.76 RAB9A (0.55) KMT2AMEN1SMN1; SMN2ALDH1A1HTT
SCHEMBL6190881 0.75 PARP1 (0.47) KMT2AMEN1SMN1; SMN2HTTNPSR1
SCHEMBL6185980 0.74 LMNA (0.41) KMT2AGAASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed